1-4 of 4
Beverley J. Hunt, MD
Close
Sort by
Journal Articles

Complement Activation In Patients with Isolated Antiphospholipid Antibodies (aPL) or Primary Antiphospholipid Syndrome (PAPS)

Karen A Breen, MB, Kiran Parmar, MSc, Beverley J Hunt, MD
Journal: Blood
Blood (2010) 116 (21): 4216.
https://doi.org/10.1182/blood.V116.21.4216.4216
Published: 2010
Journal Articles

The Utility of Thromboelastography (TEG) In the Management of Patients with Isolated Antiphospholipid Antibodies (aPL) or Primary Antiphospholipid Syndrome (PAPS)

Karen A Breen, MB, Beverley J Hunt, MD
Journal: Blood
Blood (2010) 116 (21): 3179.
https://doi.org/10.1182/blood.V116.21.3179.3179
Published: 2010
Journal Articles

Myeloproliferative Disorders Are Associated with an Increase in Levels of Prothrombotic and Inflammatory Markers Despite Cytoreductive Therapy.

Betty Y.Y. Cheung, MRCP, MRCPath, Beverley J. Hunt, MD FRCPath, Kiran Parmar, MSc, Yvonne Daniel, MSc, Deepti Radia, MRCP MRCPath, Claire N. Harrison, MD MRCPath
Journal: Blood
Blood (2006) 108 (11): 3625.
https://doi.org/10.1182/blood.V108.11.3625.3625
Published: 2006
Journal Articles

The Use of the PFA-100 ® and Thromboelastograph in Assessing Haemostasis and Drug Efficacy in Essential Thrombocythemia.

Betty Y.Y. Cheung, MBBS, Kiran Parmar, MSc, Ghasem Yadegarfar, PhD, Beverley J. Hunt, MD, Claire N. Harrison, DM
Journal: Blood
Blood (2005) 106 (11): 4959.
https://doi.org/10.1182/blood.V106.11.4959.4959
Published: 2005